Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boceprevir + SOC in Previously Treated Chronic Hepatitis C Genotype 1 with Cirrhosis
NCT01756079Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2013
- Primary completion
- Nov 2015
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of boceprevir in hepatitis C (HCV), sponsored by Merck & Co.. Started Feb 2013; status: completed.
02
Drugs
boceprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01756079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01756079.